ONO EI-601(155023-59-9)
- Name: ONO EI-601
- Synonyms:EI 601;ONO-EI 601
- Molecular Formula:C15H14 N2 O6 S
- Molecular Weight:350.352
- CAS Registry Number:155023-59-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.155023-59-9 Sivelestat Impurity 2
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
CAS No.155023-59-9 ONO EI-601
Assay:98% Appearance:Powder Package:inquiry Storage:Store in a cool and dry place and at 0 - 4 掳C for short term (days to weeks) or -20 掳C for long term (months to years). Transportation:inquiry Application:ONO EI-601, a sulfonylamine derivative, is one metabolite of ONO-5046 which is a neutrophil elastase inhibitor that could be effective against acute lung injury.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 6856-47-9/dichlorobis(3-pyridylcarboxamide-N1)cobalt
- 55567-80-1/2-Propenoic acid, 2-methyl-, butyl ester, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate and oxiranylmethyl 2-methyl-2-propenoate
- 111070-39-4/5-(benzyloxycarbonyllysylthioamido)isophthalic acid dimethyl ester
- 9023-12-5/Vitamin D sulfokinase
- 645-13-6/4'-Isopropylacetophenone
- 75115-21-8/ethyl {4-[2-(tert-butylamino)-1-hydroxyethyl]-2-cyano-6-fluorophenyl}carbamate hydrochloride
- 72462-83-0/2-[(2,3,5,6-tetramethylphenyl)sulfanyl]propanoic acid
- 90027-88-6/Daphne laureola, ext.
- 94-12-2/N-PROPYL 4-AMINOBENZOATE
- 78383-23-0/4-phenyl-2,3-dihydro-1H-inden-2-yl 3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
- 5570-96-7/4-[(E)-(diphenylhydrazono)methyl]-N,N-dimethylaniline
- 32047-63-5/5-[3-(Diethylamino)propyl]-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepine
- 136817-01-1/{4-[3-(tert-butylamino)pyridin-2-yl]piperazin-1-yl}(1H-indol-2-yl)methanone
- 56390-09-1/Epirubicin hydrochloride
- 84529-59-9/N-(2-bromo-4-chlorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline
- 58844-74-9/2-{[3-(trifluoromethyl)phenyl]sulfonyl}benzoic acid
- 6295-63-2/2-(4-chloro-3-nitrophenyl)-2-oxoethyl 6-bromo-8-methyl-2-[4-(4-methyl-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-isoindol-2-yl)phenyl]quinoline-4-carboxylate
- 155023-59-9/ONO EI-601
- 94-24-6/Tetracaine
- 79-00-5/1,1,2-Trich loroethane
- 2107-76-8/5,7-Dihydroxy-4-methylcoumarin
- 66880-80-6/B 30-muramyl dipeptide
- 1404-74-6/Streptovarycin
- 98326-38-6/6-[4-(pyridin-4-ylamino)phenyl]pyridazin-3(2H)-one
- 69937-10-6/Quadrigemine B
- 107332-47-8/[1S-(1beta,2alpha(5Z),3alpha,4beta)]-7-[3-[[[[(1-Oxoheptyl)amino]acetyl]amino]methyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid
- 5557-48-2/4-[(4-chlorobenzyl)sulfanyl]-5-methoxy-2-phenylpyridazin-3(2H)-one
- 127-71-9/Sulfabenzamide
- 82429-96-7/Benzenepropanoic acid, alpha-hydroxy-, sodium salt
- 73341-53-4/2-hydroxyamino-6-methyldipyrido(1,2-a-3',2'-d)imidazole